Target intelligence / Profile preview

Vascular stenosis

01

Overview

Vascular stenosis refers to the pathological narrowing of blood vessels, most commonly arteries, due to atherosclerosis (plaque buildup of cholesterol, fats, and other substances), leading to restricted blood flow, reduced oxygen and nutrient delivery to tissues, and strain on the cardiovascular system. This condition manifests in specific forms such as carotid artery stenosis (increasing stroke risk), aortic valve stenosis (causing heart strain and potential failure), coronary artery stenosis (leading to ischemia), renal artery stenosis (contributing to hypertension and kidney damage), and peripheral artery stenosis (causing limb pain and ischemia). It arises from risk factors like high cholesterol, hypertension, smoking, diabetes, and aging, progressively worsening if untreated and potentially resulting in severe complications including heart attack, stroke, organ failure, or limb loss. Diagnosis relies on imaging like ultrasound, CT angiography, or MRI to measure stenosis severity (e.g., >50-60% narrowing often prompts intervention). Treatments emphasize lifestyle changes, medical therapy to manage risk factors (statins, antiplatelets), and revascularization procedures such as carotid endarterectomy (CEA), stenting (CAS), or transcarotid artery revascularization (TCAR) for significant blockages. While effective, these interventions carry risks like perioperative stroke or restenosis, with guidelines favoring early action in symptomatic cases. Overall, vascular stenosis underscores the need for cardiovascular risk prevention, as it is not a discrete molecular target but a multifocal disease process amenable to mechanical and conservative management.

Other names
Blood vessel narrowingarterial stenosisvascular narrowing
02

Disease associations

Cardiovascular diseasestroke risk (e.g., carotid stenosis)hypertension (e.g., renal artery stenosis)heart complications (e.g., coronary or aortic stenosis)peripheral vascular disease
03

Safety considerations

Procedural risks from revascularization (e.g., stroke, restenosis after stenting or endarterectomy)gender-dependent outcomesthrombosis in high-risk casesneointimal hyperplasia post-intervention
04

Interacting drugs

Antiplatelet agents (e.g., aspirin)

2 more in the full profile.

05

Biomarkers

Imaging-based (e.g., ultrasound peak systolic velocity >125-230 cm/s, diameter reduction >50%, CT angiography)flow volume decreases

Beyond the preview

Go deeper on Vascular stenosis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular stenosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call